ins 2021 - abstract autho… · abstract number first name last name do you (or your spouse or...

Abstract

Number

First Name Last Name Do you (or

your spouse

or partner)

have any

relevant

financial

relationships

with any

commercial

interests

related,

directly or

indirectly, to

the subject of

this

presentation?

For what

role?

Commercial

Interest /

Company

Level of

Compensation

For what

role?

Commercial

Interest /

Company

Level of

Compensation

For what

role?

Commercial

Interest /

Company

Level of

Compensation

For what

role?

Commercial

Interest /

Company

Level of

Compensation

Do you (or

your spouse

or partner)

have any

relevant

financial

relationships

with any

commercial

interests

related,

directly or

indirectly, to

the subject of

this

presentation?

Identifying

Products,

Reporting on

Research, and

Discussing

Unlabeled

Uses of

Products A

Does your

article/present

ation include

discussion of

any

commercial

products or

services?

If Yes, please

clarify

Identifying Products, Reporting on

Research, and Discussing

Unlabeled Uses of Products B If

you answered Yes to Identifying

Products, Reporting on Research,

and Discussing Unlabeled Uses of

Products A, please indicate you

have read each of the ACCME

Standards for Commercial Support

of Continuing Medical Education

I certify that the information I have

provided is true and complete to

the best of my knowledge. I

understand that relevant financial

relationships (last 12 months) with

any commercial company whose

product(s) I may discuss in my

educational presentation or

enduring material must be

disclosed prior to and will be listed

in the materials for the EACCME

certified activities.

INS19-0228 Yan Meng Speaker

Program

$500 - $5,000

USD

No, I do not

have any

relevant

financial

relationships

No I answered No to A (not applicable) Fair Balance Certification

INS19-0398 Xiaofeng Yang No, I do not

have any

relevant

financial

relationships

No I answered No to A (not applicable) Best Available

Evidence

Certification

INS19-0415 Sung Min Lim No, I do not

have any

relevant

financial

relationships

No I answered No to A (not applicable) Scientific

Integrity

Certification

INS19-0363 Alaa Abd-Elsayed Yes Consultant /

Advisory

Board

StimWave $5,001-

$20,000 USD

Consultant /

Advisory

Board

SpineLoop $5,001-

$20,000 USD

Consultant /

Advisory

Board

Halyard $5,001-

$20,000 USD

Consultant /

Advisory

Board

Medtronic $5,001-

$20,000 USD

I will support

my

presentation

and clinical

recommendati

ons with the

“best available

evidence”

from the

medical

literature.

I will refrain

from making

recommendati

ons, re:

products or

services, e.g.,

limit

presentation

to

pathophysiolo

gy, diagNosis,

and/or

research

findings

I will submit

my abstract(s)

and slides in

advance to

allow for

adequate peer

review.


Evidence

Certification

INS19-0108 Alain Ptito Yes Education /

Research

$5,001-

$20,000 USD

Company

Employee

Helius Medical I will support

my

presentation

and clinical

recommendati

ons with the

“best available

evidence”

from the

medical

literature.

I will refrain

from making

recommendati

ons, re:

products or

services, e.g.,

limit

presentation

to

pathophysiolo

gy, diagNosis,

and/or

research

findings

Yes PoNS device

used in our

research study

I have read each of the following

ACCME Standards for Commercial

Support of Continuing Medical

Education

Fair Balance Best Available

Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

INS19-0313 Andrew Leuchter Yes Consultant /

Advisory

Board

NeoSync, Inc. Stock

Options

Brain

Biomarker

Analytics,

LLC

Stockholder

Stock Value

>5%

Neuronetics,

Inc.

Education /

Research

NeoSync, Inc. I will support

my

presentation

and clinical

recommendati

ons with the

“best available

evidence”

from the

medical

literature.

I will submit

my abstract(s)

and slides in

advance to

allow for

adequate peer

review.

Yes TMS devices I have read each of the following



Education


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

INS19-0165 Alexander Kent Yes Company

Employee

Abbott > $20,000 USD Stockholder > $20,000 USD Company

Employee

Abbott I will support

my

presentation

and clinical

recommendati

ons with the

“best available

evidence”

from the

medical

literature.

I will refrain

from making

recommendati

ons, re:

products or

services, e.g.,

limit

presentation

to

pathophysiolo

gy, diagNosis,

and/or

research

findings

I will submit

my abstract(s)

and slides in

advance to

allow for

adequate peer

review.

Yes BurstDR spinal

cord

stimulation




Education


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

INS19-0328 Alexander Kent Yes Company

Employee

Abbott > $20,000 USD Stockholder > $20,000 USD Company

Employee


my

presentation

and clinical

recommendati

ons with the

“best available

evidence”

from the

medical

literature.

I will refrain

from making

recommendati

ons, re:

products or

services, e.g.,

limit

presentation

to

pathophysiolo

gy, diagNosis,

and/or

research

findings

I will submit

my abstract(s)

and slides in

advance to

allow for

adequate peer

review.

Yes BurstDR spinal

cord

stimulation




Education


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

INS19-0081 Alexios CarayanNopo

ulos

Consultant /

Advisory

Board

$500 - $5,000

USD

No, I do not

have any

relevant

financial

relationships

No I answered No to A (not applicable) Fair Balance Best Available

Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

INS19-0189 Allison Foster Consultant /

Advisory

Board

$500 - $5,000

USD

No, I do not

have any

relevant

financial

relationships

I will support

my

presentation

and clinical

recommendati

ons with the

“best available

evidence”

from the

medical

literature.

I will refrain

from making

recommendati

ons, re:

products or

services, e.g.,

limit

presentation

to

pathophysiolo

gy, diagNosis,

and/or

research

findings


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

INS19-0123 Amir Dagan Yes Stock

Options

> $20,000 USD Company

Employee

Company CEO Yes Presenting a

product under

development




Education

Scientific

Integrity

Certification

INS19-0323 Angela Santos Yes Company

Employee


Employee

Nevro Corp. No I answered No to A (not applicable) Fair Balance Best Available

Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

INS19-0421 Andrea Landi No, I do not

have any

relevant

financial

relationships


Integrity

Certification

INS19-0359 Anuj Bhatia No, I do not

have any

relevant

financial

relationships


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

INS19-0103 ASHISH GULVE Yes Speaker

Program

NEVRO $500 - $5,000

USD

Speaker

Program

Boston

Scientific

$500 - $5,000

USD

Speaker

Program

Abbott

Medical

$500 - $5,000

USD

Speaker

Program

Medtronic $500 - $5,000

USD

I will submit

my abstract(s)

and slides in

advance to

allow for

adequate peer

review.



Program

NEVRO $500 - $5,000

USD

Speaker

Program

Boston

Scientific

$500 - $5,000

USD

Speaker

Program

Abbott

Medical

$500 - $5,000

USD

Speaker

Program

Medtronic $500 - $5,000

USD

I will submit

my abstract(s)

and slides in

advance to

allow for

adequate peer

review.



Program

NEVRO $500 - $5,000

USD

Speaker

Program

Boston

Scientific

$500 - $5,000

USD

Speaker

Program

Abbott

Medical

$500 - $5,000

USD

Speaker

Program

Medtronic $500 - $5,000

USD

I will submit

my abstract(s)

and slides in

advance to

allow for

adequate peer

review.


INS19-0085 Robert Frey Yes Consultant /

Advisory

Board

$500 - $5,000

USD

Company

Employee

Boston

Scientific

I will refrain

from making

recommendati

ons, re:

products or

services, e.g.,

limit

presentation

to

pathophysiolo

gy, diagNosis,

and/or

research

findings

I will submit

my abstract(s)

and slides in

advance to

allow for

adequate peer

review.


Integrity

Certification

INS19-0167 Robert Frey Yes Consultant /

Advisory

Board

$500 - $5,000

USD

Company

Employee

Boston

Scientific

I will refrain

from making

recommendati

ons, re:

products or

services, e.g.,

limit

presentation

to

pathophysiolo

gy, diagNosis,

and/or

research

findings

I will submit

my abstract(s)

and slides in

advance to

allow for

adequate peer

review.


Integrity

Certification

INS19-0426 Atilla YILMAZ Yes Consultant /

Advisory

Board

Medtronic Consultant /

Advisory

Board

Abbot Consultant /

Advisory

Board

Company

Employee

Boston

Sceintific

I will support

my

presentation

and clinical

recommendati

ons with the

“best available

evidence”

from the

medical

literature.


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification


Advisory

Board

Boston

Scientific

Consultant /

Advisory

Board

Abbot Consultant /

Advisory

Board

Company

Employee

Medtronic I will support

my

presentation

and clinical

recommendati

ons with the

“best available

evidence”

from the

medical

literature.


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification


Advisory

Board


Advisory

Board

Abbot Consultant /

Advisory

Board

Company

Employee

Boston

Sceintific

I will support

my

presentation

and clinical

recommendati

ons with the

“best available

evidence”

from the

medical

literature.


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

INS19-0433 Atilla YIlmaz Yes Consultant /

Advisory

Board


Advisory

Board

Abbot Consultant /

Advisory

Board

Company

Employee

Boston

Sceintific

I will support

my

presentation

and clinical

recommendati

ons with the

“best available

evidence”

from the

medical

literature.


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

INS19-0208 Andrey Ashurkov No, I do not

have any

relevant

financial

relationships


Integrity

Certification

Do you feel that you have a conflict of interest as an author or presenter based

on the disclosure information provided? If you have a conflict to resolve,

please check one or more of the following options:

Faculty Verification of CME Independence and Content Validity

Check each box to attest to your understanding of and

willingness to comply with the corresponding statement.

INS19-0393 Andrey Ashurkov No, I do not

have any

relevant

financial

relationships


Integrity

Certification

INS19-0127 bertil blok No, I do not

have any

relevant

financial

relationships


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

INS19-0205 Basabjit Das No, I do not

have any

relevant

financial

relationships


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

INS19-0421 Alberto Benato No, I do not

have any

relevant

financial

relationships


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

INS19-0051 Werner Braunsdorf Speaker

Program

Klinikum

Magdeburg

gGmbH

$500 - $5,000

USD

Company

Employee

Klinikum

Magdeburg

gGmbH

Company

Employee

Klinikum

Magdeburg

gGmbH

Company

Employee

Klinikum

Magdeburg

gGmbH

No, I do not

have any

relevant

financial

relationships


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

INS19-0216 Silke Kretzschmar Education /

Research

$500 - $5,000

USD

Company

Employee

GSK No, I do not

have any

relevant

financial

relationships


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

INS19-0227 Brittney Misercola Yes Speaker

Program

$500 - $5,000

USD

Company

Employee

Abbott No I answered No to A (not applicable) Best Available

Evidence

Certification

INS19-0241 Brittney Misercola No, I do not

have any

relevant

financial

relationships


Evidence

Certification

INS19-0246 Brittney Misercola No, I do not

have any

relevant

financial

relationships


Evidence

Certification

Camille Matthys Education /

Research

$500 - $5,000

USD

No, I do not

have any

relevant

financial

relationships


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

INS19-0120 craig comiter Yes Consultant /

Advisory

Board

$500 - $5,000

USD

Company

Employee

neuspera I will support

my

presentation

and clinical

recommendati

ons with the

“best available

evidence”

from the

medical

literature.

I will submit

my abstract(s)

and slides in

advance to

allow for

adequate peer

review.

Yes neuspera

product




Education


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

INS19-0070 Celestina Isiramen Company

Employee

> $20,000 USD No, I do not

have any

relevant

financial

relationships


INS19-0338 Kenneth Chapman No, I do not

have any

relevant

financial

relationships


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

INS19-0339 Kenneth Chapman No, I do not

have any

relevant

financial

relationships


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

INS19-0289 Charles Brooker Yes Speaker

Program

$500 - $5,000

USD

Company

Employee

Saluda

Medical

Yes Presenting

research data

on

investigational

device




Education


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

INS19-0375 Charles Brooker Yes Consultant /

Advisory

Board

Abbott,

Medtronic

Inc,

Phosphageni

cs,

RRMedscienc

es, Saluda

Medical Pty.

Ltd., and

Spinal

Modulation

$500 - $5,000

USD

Education /

Research

$500 - $5,000

USD

Company

Employee

Sequirus No I answered No to A (not applicable) Fair Balance Best Available

Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification


Program

$500 - $5,000

USD

Company

Employee

Saluda

Medical

Yes Presenting

research data

on

investigational

device




Education


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification


Advisory

Board

Abbott,

Medtronic

Inc,

Phosphageni

cs,

RRMedscienc

es, Saluda

Medical Pty.

Ltd., and

Spinal

Modulation

$500 - $5,000

USD

Education /

Research

$500 - $5,000

USD

Company

Employee


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification


Program

$500 - $5,000

USD

Company

Employee

Saluda

Medical

Yes Presenting

research data

on

investigational

device




Education


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification


Advisory

Board

Abbott,

Medtronic

Inc,

Phosphageni

cs,

RRMedscienc

es, Saluda

Medical Pty.

Ltd., and

Spinal

Modulation

$500 - $5,000

USD

Education /

Research

$500 - $5,000

USD

Company

Employee


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

Colleen Marie Yes Stockholder > $20,000 USD Company

Employee

Test 1 I will support

my

presentation

and clinical

recommendati

ons with the

“best available

evidence”

from the

medical

literature.

Yes Test I have read each of the following



Education


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

INS19-0188 Chinyere Archie Speaker

Program

$500 - $5,000

USD

No, I do not

have any

relevant

financial

relationships


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

INS19-0052 chris kao Speaker

Program

$500 - $5,000

USD

Company

Employee

PINS No, I do not

have any

relevant

financial

relationships


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

Christine Ricker Yes Stockholder Medtronic > $20,000 USD Company

Employee


Employee

Medtronic I will refrain

from making

recommendati

ons, re:

products or

services, e.g.,

limit

presentation

to

pathophysiolo

gy, diagNosis,

and/or

research

findings

I will submit

my abstract(s)

and slides in

advance to

allow for

adequate peer

review.

Yes Discusses

IDDS, but with

No reference

to specific

product

names.




Education


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

INS19-0179 Christophe Perruchoud Yes Consultant /

Advisory

Board

Boston

Scientific

$500 - $5,000

USD

Education /

Research

$500 - $5,000

USD

Company

Employee

Medtronic I will support

my

presentation

and clinical

recommendati

ons with the

“best available

evidence”

from the

medical

literature.

I will refrain

from making

recommendati

ons, re:

products or

services, e.g.,

limit

presentation

to

pathophysiolo

gy, diagNosis,

and/or

research

findings

I will

recommend

an alternative

presenter for

this topic for

the Scientific

Program

Committee’s

consideration.

I will submit

my abstract(s)

and slides in

advance to

allow for

adequate peer

review.

I will or have

divested

myself of this

financial

relationship.

Yes Synchromed II I have read each of the following



Education


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

INS19-0287 Chung-Chin Kuo No, I do not

have any

relevant

financial

relationships


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

INS19-0153 Corey Hunter Yes Consultant /

Advisory

Board

Saluda > $20,000 USD Consultant /

Advisory

Board

Nuvectra $5,001-

$20,000 USD

Consultant /

Advisory

Board


Employee


my

presentation

and clinical

recommendati

ons with the

“best available

evidence”

from the

medical

literature.

I will refrain

from making

recommendati

ons, re:

products or

services, e.g.,

limit

presentation

to

pathophysiolo

gy, diagNosis,

and/or

research

findings

I will submit

my abstract(s)

and slides in

advance to

allow for

adequate peer

review.

Yes I have read each of the following



Education


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification


Advisory

Board


Advisory

Board

Nuvectra $5,001-

$20,000 USD

Consultant /

Advisory

Board


Employee


my

presentation

and clinical

recommendati

ons with the

“best available

evidence”

from the

medical

literature.

I will refrain

from making

recommendati

ons, re:

products or

services, e.g.,

limit

presentation

to

pathophysiolo

gy, diagNosis,

and/or

research

findings

I will submit

my abstract(s)

and slides in

advance to

allow for

adequate peer

review.




Education


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification


Advisory

Board


Advisory

Board

Nuvectra $5,001-

$20,000 USD

Consultant /

Advisory

Board


Employee


my

presentation

and clinical

recommendati

ons with the

“best available

evidence”

from the

medical

literature.

I will refrain

from making

recommendati

ons, re:

products or

services, e.g.,

limit

presentation

to

pathophysiolo

gy, diagNosis,

and/or

research

findings

I will submit

my abstract(s)

and slides in

advance to

allow for

adequate peer

review.




Education


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification


Advisory

Board


Advisory

Board

Nuvectra $5,001-

$20,000 USD

Consultant /

Advisory

Board


Employee


my

presentation

and clinical

recommendati

ons with the

“best available

evidence”

from the

medical

literature.

I will refrain

from making

recommendati

ons, re:

products or

services, e.g.,

limit

presentation

to

pathophysiolo

gy, diagNosis,

and/or

research

findings

I will submit

my abstract(s)

and slides in

advance to

allow for

adequate peer

review.




Education


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification


Advisory

Board

Vertiflex > $20,000 USD Consultant /

Advisory

Board


Advisory

Board

Nuvectra $5,001-

$20,000 USD

Consultant /

Advisory

Board

Abbott $500 - $5,000

USD

I will support

my

presentation

and clinical

recommendati

ons with the

“best available

evidence”

from the

medical

literature.

I will refrain

from making

recommendati

ons, re:

products or

services, e.g.,

limit

presentation

to

pathophysiolo

gy, diagNosis,

and/or

research

findings

I will submit

my abstract(s)

and slides in

advance to

allow for

adequate peer

review.

Yes Will discuss

techNologies

& therapies

owned by

companies I

consult for




Education


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

INS19-0221 Claire Marie RANGON No, I do not

have any

relevant

financial

relationships


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

INS19-0061 Chima Oluigbo No, I do not

have any

relevant

financial

relationships


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

INS19-0321 Chima Oluigbo No, I do not

have any

relevant

financial

relationships


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

INS19-0237 Amy Crepeau No, I do not

have any

relevant

financial

relationships


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

INS19-0292 Danielle Hewitt Yes Education /

Research


Employee

Abbott I will refrain

from making

recommendati

ons, re:

products or

services, e.g.,

limit

presentation

to

pathophysiolo

gy, diagNosis,

and/or

research

findings

Yes My poster

presentation

will discuss

our study in

which we

utilised

parasthesia

and

parasthesia-

free spinal

cord

stimulators -

traditional

tonic

waveforms

and BurstDR

waveforms,

the latter of

which is

manufactured

by Abbott.




Education


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

INS19-0224 David Karpul Education /

Research


Employee

Western

Sydney

University

No, I do not

have any

relevant

financial

relationships


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

INS19-0307 Daniel Alves Neiva

Barbosa

No, I do not

have any

relevant

financial

relationships


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

INS19-0134 Dan Bates Yes Consultant /

Advisory

Board

Nevro $5,001-

$20,000 USD

Consultant /

Advisory

Board

Nalu $500 - $5,000

USD

Consultant /

Advisory

Board

$500 - $5,000

USD

Company

Employee


my

presentation

and clinical

recommendati

ons with the

“best available

evidence”

from the

medical

literature.

I will refrain

from making

recommendati

ons, re:

products or

services, e.g.,

limit

presentation

to

pathophysiolo

gy, diagNosis,

and/or

research

findings

I will submit

my abstract(s)

and slides in

advance to

allow for

adequate peer

review.

Yes Discussion of

current

evidence base

around HF10,

DRG

stimulation,

Burst

stimulation,

this is

discussed

relative to the

current

international

guidelines on

the use of

neuromodulat

ion for

neuropathic

pain.

I answered No to A (not applicable) Fair Balance Best Available

Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification


Advisory

Board

Nevro $5,001-

$20,000 USD

Consultant /

Advisory

Board

Nalu $500 - $5,000

USD

Consultant /

Advisory

Board

$500 - $5,000

USD

Company

Employee


my

presentation

and clinical

recommendati

ons with the

“best available

evidence”

from the

medical

literature.

I will refrain

from making

recommendati

ons, re:

products or

services, e.g.,

limit

presentation

to

pathophysiolo

gy, diagNosis,

and/or

research

findings

I will submit

my abstract(s)

and slides in

advance to

allow for

adequate peer

review.

Yes Discussion of

current

evidence base

around HF10,

DRG

stimulation,

Burst

stimulation,

this is

discussed

relative to the

current

international

guidelines on

the use of

neuromodulat

ion for

neuropathic

pain.


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification


Advisory

Board

Nevro $5,001-

$20,000 USD

Consultant /

Advisory

Board

Nalu $500 - $5,000

USD

Consultant /

Advisory

Board

$500 - $5,000

USD

Company

Employee


my

presentation

and clinical

recommendati

ons with the

“best available

evidence”

from the

medical

literature.

I will refrain

from making

recommendati

ons, re:

products or

services, e.g.,

limit

presentation

to

pathophysiolo

gy, diagNosis,

and/or

research

findings

I will submit

my abstract(s)

and slides in

advance to

allow for

adequate peer

review.

Yes Discussion of

current

evidence base

around HF10,

DRG

stimulation,

Burst

stimulation,

this is

discussed

relative to the

current

international

guidelines on

the use of

neuromodulat

ion for

neuropathic

pain.


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification


Advisory

Board

Nevro $5,001-

$20,000 USD

Consultant /

Advisory

Board

Nalu $500 - $5,000

USD

Consultant /

Advisory

Board

$500 - $5,000

USD

Company

Employee


my

presentation

and clinical

recommendati

ons with the

“best available

evidence”

from the

medical

literature.

I will refrain

from making

recommendati

ons, re:

products or

services, e.g.,

limit

presentation

to

pathophysiolo

gy, diagNosis,

and/or

research

findings

I will submit

my abstract(s)

and slides in

advance to

allow for

adequate peer

review.

Yes Discussion of

current

evidence base

around HF10,

DRG

stimulation,

Burst

stimulation,

this is

discussed

relative to the

current

international

guidelines on

the use of

neuromodulat

ion for

neuropathic

pain.


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

INS19-0109 David CedeNo Consultant /

Advisory

Board

$500 - $5,000

USD

No, I do not

have any

relevant

financial

relationships

I will support

my

presentation

and clinical

recommendati

ons with the

“best available

evidence”

from the

medical

literature.

I will refrain

from making

recommendati

ons, re:

products or

services, e.g.,

limit

presentation

to

pathophysiolo

gy, diagNosis,

and/or

research

findings

I will

recommend

an alternative

presenter for

this topic for

the Scientific

Program

Committee’s

consideration.

I will submit

my abstract(s)

and slides in

advance to

allow for

adequate peer

review.

I will or have

divested

myself of this

financial

relationship.


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification


Advisory

Board

$500 - $5,000

USD

No, I do not

have any

relevant

financial

relationships

I will support

my

presentation

and clinical

recommendati

ons with the

“best available

evidence”

from the

medical

literature.

I will refrain

from making

recommendati

ons, re:

products or

services, e.g.,

limit

presentation

to

pathophysiolo

gy, diagNosis,

and/or

research

findings

I will

recommend

an alternative

presenter for

this topic for

the Scientific

Program

Committee’s

consideration.

I will submit

my abstract(s)

and slides in

advance to

allow for

adequate peer

review.

I will or have

divested

myself of this

financial

relationship.


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification


Advisory

Board

$500 - $5,000

USD

No, I do not

have any

relevant

financial

relationships

I will support

my

presentation

and clinical

recommendati

ons with the

“best available

evidence”

from the

medical

literature.

I will refrain

from making

recommendati

ons, re:

products or

services, e.g.,

limit

presentation

to

pathophysiolo

gy, diagNosis,

and/or

research

findings

I will

recommend

an alternative

presenter for

this topic for

the Scientific

Program

Committee’s

consideration.

I will submit

my abstract(s)

and slides in

advance to

allow for

adequate peer

review.

I will or have

divested

myself of this

financial

relationship.


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification


Advisory

Board

$500 - $5,000

USD

No, I do not

have any

relevant

financial

relationships

I will support

my

presentation

and clinical

recommendati

ons with the

“best available

evidence”

from the

medical

literature.

I will refrain

from making

recommendati

ons, re:

products or

services, e.g.,

limit

presentation

to

pathophysiolo

gy, diagNosis,

and/or

research

findings

I will

recommend

an alternative

presenter for

this topic for

the Scientific

Program

Committee’s

consideration.

I will submit

my abstract(s)

and slides in

advance to

allow for

adequate peer

review.

I will or have

divested

myself of this

financial

relationship.


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification


Advisory

Board

$500 - $5,000

USD

No, I do not

have any

relevant

financial

relationships

I will support

my

presentation

and clinical

recommendati

ons with the

“best available

evidence”

from the

medical

literature.

I will refrain

from making

recommendati

ons, re:

products or

services, e.g.,

limit

presentation

to

pathophysiolo

gy, diagNosis,

and/or

research

findings

I will

recommend

an alternative

presenter for

this topic for

the Scientific

Program

Committee’s

consideration.

I will submit

my abstract(s)

and slides in

advance to

allow for

adequate peer

review.

I will or have

divested

myself of this

financial

relationship.


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

INS19-0240 denise taylor No, I do not

have any

relevant

financial

relationships


Evidence

Sources and

Limitations of

Data

Certification


have any

relevant

financial

relationships


Evidence

Sources and

Limitations of

Data

Certification


have any

relevant

financial

relationships


Evidence

Sources and

Limitations of

Data

Certification


have any

relevant

financial

relationships


Evidence

Sources and

Limitations of

Data

Certification

INS19-0104 Dirk Rasche Education /

Research

$500 - $5,000

USD

Company

Employee

Abbott No, I do not

have any

relevant

financial

relationships


Evidence

Certification

INS19-0152 Dirk Rasche Education /

Research

No, I do not

have any

relevant

financial

relationships

I will support

my

presentation

and clinical

recommendati

ons with the

“best available

evidence”

from the

medical

literature.

I will refrain

from making

recommendati

ons, re:

products or

services, e.g.,

limit

presentation

to

pathophysiolo

gy, diagNosis,

and/or

research

findings


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

INS19-0386 Dirk Rasche No, I do not

have any

relevant

financial

relationships

I will support

my

presentation

and clinical

recommendati

ons with the

“best available

evidence”

from the

medical

literature.

I will refrain

from making

recommendati

ons, re:

products or

services, e.g.,

limit

presentation

to

pathophysiolo

gy, diagNosis,

and/or

research

findings


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

INS19-0265 Di Zhao Education /

Research

$500 - $5,000

USD

No, I do not

have any

relevant

financial

relationships


Integrity

Certification

INS19-0309 David Page Yes Company

Employee


Employee

AvaNos

Medical

I will support

my

presentation

and clinical

recommendati

ons with the

“best available

evidence”

from the

medical

literature.

I will refrain

from making

recommendati

ons, re:

products or

services, e.g.,

limit

presentation

to

pathophysiolo

gy, diagNosis,

and/or

research

findings

I will submit

my abstract(s)

and slides in

advance to

allow for

adequate peer

review.




Education


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

INS19-0153 Björn Carsten Schultheis Yes Consultant /

Advisory

Board

$500 - $5,000

USD

Company

Employee


my

presentation

and clinical

recommendati

ons with the

“best available

evidence”

from the

medical

literature.

Yes Abbott Burst

DR


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

INS19-0171 Björn Carsten Schultheis Yes Consultant /

Advisory

Board

$500 - $5,000

USD

Company

Employee


my

presentation

and clinical

recommendati

ons with the

“best available

evidence”

from the

medical

literature.

Yes Abbott Burst

DR


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

INS19-0045 Timothy Deer Yes Consultant /

Advisory

Board

Axonics,

Vertos,

Saluda

> $20,000 USD Consultant /

Advisory

Board

Jazz Pharm $5,001-

$20,000 USD

Speaker

Program

Nalu

Medical,

Nevro,

Flowonix,

SpineThera,

Vertiflex

$500 - $5,000

USD

Consultant /

Advisory

Board

Abbott $500 - $5,000

USD

I will support

my

presentation

and clinical

recommendati

ons with the

“best available

evidence”

from the

medical

literature.

I will submit

my abstract(s)

and slides in

advance to

allow for

adequate peer

review.


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification


Advisory

Board

Axonics,

Saluda

Medical,

Vertos


Advisory

Board

Bioness, Jazz

Pharm, Nalu,

Nevro,

Flowonix,

SpineThera,

Vertiflex

$5,001-

$20,000 USD

Consultant /

Advisory

Board

Axonics,

Bioness,

Nalu, saluda,

Vertos,

Vertiflex,

SpinThera,

Conerloc

$500 - $5,000

USD

Stock

Options

Abbott $5,001-

$20,000 USD

I will support

my

presentation

and clinical

recommendati

ons with the

“best available

evidence”

from the

medical

literature.

I will refrain

from making

recommendati

ons, re:

products or

services, e.g.,

limit

presentation

to

pathophysiolo

gy, diagNosis,

and/or

research

findings

I will submit

my abstract(s)

and slides in

advance to

allow for

adequate peer

review.

Yes DRG, BURST

SCS




Education


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification


Advisory

Board

Axonics,

Vertos,

Saluda


Advisory

Board

Jazz Pharm $5,001-

$20,000 USD

Speaker

Program

Nalu

Medical,

Nevro,

Flowonix,

SpineThera,

Vertiflex

$500 - $5,000

USD

Consultant /

Advisory

Board

Abbott $500 - $5,000

USD

I will support

my

presentation

and clinical

recommendati

ons with the

“best available

evidence”

from the

medical

literature.

I will submit

my abstract(s)

and slides in

advance to

allow for

adequate peer

review.


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification


Advisory

Board

Axonics,

Saluda

Medical,

Vertos


Advisory

Board

Bioness, Jazz

Pharm, Nalu,

Nevro,

Flowonix,

SpineThera,

Vertiflex

$5,001-

$20,000 USD

Consultant /

Advisory

Board

Axonics,

Bioness,

Nalu, saluda,

Vertos,

Vertiflex,

SpinThera,

Conerloc

$500 - $5,000

USD

Stock

Options

Abbott $5,001-

$20,000 USD

I will support

my

presentation

and clinical

recommendati

ons with the

“best available

evidence”

from the

medical

literature.

I will refrain

from making

recommendati

ons, re:

products or

services, e.g.,

limit

presentation

to

pathophysiolo

gy, diagNosis,

and/or

research

findings

I will submit

my abstract(s)

and slides in

advance to

allow for

adequate peer

review.

Yes DRG, BURST

SCS




Education


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification


Advisory

Board

Axonics,

Vertos,

Saluda


Advisory

Board

Jazz Pharm $5,001-

$20,000 USD

Speaker

Program

Nalu

Medical,

Nevro,

Flowonix,

SpineThera,

Vertiflex

$500 - $5,000

USD

Consultant /

Advisory

Board

Abbott $500 - $5,000

USD

I will support

my

presentation

and clinical

recommendati

ons with the

“best available

evidence”

from the

medical

literature.

I will submit

my abstract(s)

and slides in

advance to

allow for

adequate peer

review.


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification


Advisory

Board

Axonics,

Saluda

Medical,

Vertos


Advisory

Board

Bioness, Jazz

Pharm, Nalu,

Nevro,

Flowonix,

SpineThera,

Vertiflex

$5,001-

$20,000 USD

Consultant /

Advisory

Board

Axonics,

Bioness,

Nalu, saluda,

Vertos,

Vertiflex,

SpinThera,

Conerloc

$500 - $5,000

USD

Stock

Options

Abbott $5,001-

$20,000 USD

I will support

my

presentation

and clinical

recommendati

ons with the

“best available

evidence”

from the

medical

literature.

I will refrain

from making

recommendati

ons, re:

products or

services, e.g.,

limit

presentation

to

pathophysiolo

gy, diagNosis,

and/or

research

findings

I will submit

my abstract(s)

and slides in

advance to

allow for

adequate peer

review.

Yes DRG, BURST

SCS




Education


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification


Advisory

Board

Axonics,

Vertos,

Saluda


Advisory

Board

Jazz Pharm $5,001-

$20,000 USD

Speaker

Program

Nalu

Medical,

Nevro,

Flowonix,

SpineThera,

Vertiflex

$500 - $5,000

USD

Consultant /

Advisory

Board

Abbott $500 - $5,000

USD

I will support

my

presentation

and clinical

recommendati

ons with the

“best available

evidence”

from the

medical

literature.

I will submit

my abstract(s)

and slides in

advance to

allow for

adequate peer

review.


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification


Advisory

Board

Axonics,

Saluda

Medical,

Vertos


Advisory

Board

Bioness, Jazz

Pharm, Nalu,

Nevro,

Flowonix,

SpineThera,

Vertiflex

$5,001-

$20,000 USD

Consultant /

Advisory

Board

Axonics,

Bioness,

Nalu, saluda,

Vertos,

Vertiflex,

SpinThera,

Conerloc

$500 - $5,000

USD

Stock

Options

Abbott $5,001-

$20,000 USD

I will support

my

presentation

and clinical

recommendati

ons with the

“best available

evidence”

from the

medical

literature.

I will refrain

from making

recommendati

ons, re:

products or

services, e.g.,

limit

presentation

to

pathophysiolo

gy, diagNosis,

and/or

research

findings

I will submit

my abstract(s)

and slides in

advance to

allow for

adequate peer

review.

Yes DRG, BURST

SCS




Education


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification


Advisory

Board

Axonics,

Vertos,

Saluda


Advisory

Board

Jazz Pharm $5,001-

$20,000 USD

Speaker

Program

Nalu

Medical,

Nevro,

Flowonix,

SpineThera,

Vertiflex

$500 - $5,000

USD

Consultant /

Advisory

Board

Abbott $500 - $5,000

USD

I will support

my

presentation

and clinical

recommendati

ons with the

“best available

evidence”

from the

medical

literature.

I will submit

my abstract(s)

and slides in

advance to

allow for

adequate peer

review.


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

INS19-0047 Harinder Jaseja No, I do not

have any

relevant

financial

relationships


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

INS19-0374 Harinder Jaseja No, I do not

have any

relevant

financial

relationships


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

INS19-0042 Hyson Hyson Speaker

Program

$500 - $5,000

USD

Company

Employee

$500 - $5,000

USD

Company

Employee

Hyson

Medical

Products

No, I do not

have any

relevant

financial

relationships


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

INS19-0038 Venkateshwar

la

Rama Raju Company

Employee

Nizam`s

Institute of

Medical

Sciences

(NIMS)

Hospital

No, I do not

have any

relevant

financial

relationships



la

Rama Raju No, I do not

have any

relevant

financial

relationships



la


have any

relevant

financial

relationships



la


have any

relevant

financial

relationships



la


have any

relevant

financial

relationships


INS19-0358 Dawood Sayed Yes Consultant /

Advisory

Board


Employee

Nevro Corp I will support

my

presentation

and clinical

recommendati

ons with the

“best available

evidence”

from the

medical

literature.

I will refrain

from making

recommendati

ons, re:

products or

services, e.g.,

limit

presentation

to

pathophysiolo

gy, diagNosis,

and/or

research

findings

Yes 10 kHz high-

frequency

stimulation

used for spinal

cord

stimulation is

only available

through Nevro

Corp. Their

company

name is not

mentioned

but the

therapy is.




Education


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

INS19-0166 Dawood Sayed Yes Consultant /

Advisory

Board


Employee

Nevro I will support

my

presentation

and clinical

recommendati

ons with the

“best available

evidence”

from the

medical

literature.

I will refrain

from making

recommendati

ons, re:

products or

services, e.g.,

limit

presentation

to

pathophysiolo

gy, diagNosis,

and/or

research

findings

I will

recommend

an alternative

presenter for

this topic for

the Scientific

Program

Committee’s

consideration.

I will submit

my abstract(s)

and slides in

advance to

allow for

adequate peer

review.

I will or have

divested

myself of this

financial

relationship.

Yes Nevro

stimulator




Education


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

INS19-0269 Emil Isagulyan No, I do not

have any

relevant

financial

relationships



have any

relevant

financial

relationships



have any

relevant

financial

relationships


INS19-0228 YILING ZHANG Education /

Research

$500 - $5,000

USD

Company

Employee

Johns Hopkins

University

No, I do not

have any

relevant

financial

relationships

I will or have

divested

myself of this

financial

relationship.


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

INS19-0257 YILING ZHANG Education /

Research

$500 - $5,000

USD

Company

Employee

Johns Hopkins

University

No, I do not

have any

relevant

financial

relationships


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

INS19-0146 Joanne Lascelles No, I do not

have any

relevant

financial

relationships


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

INS19-0344 Joanne Lascelles No, I do not

have any

relevant

financial

relationships


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

INS19-0311 Stefania Ficarella No, I do not

have any

relevant

financial

relationships


Integrity

Certification

INS19-0135 Steven Rosen Yes Consultant /

Advisory

Board

Biotronik,

Flowonix

Medical Inc.,

Medtronic,

Nevro Corp,

and Saluda

Medical Pty.

Ltd.

$5,001-

$20,000 USD

Education /

Research

$5,001-

$20,000 USD

Company

Employee

Saluda

Medical Pty.

Ltd.


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

INS19-0380 Steven Rosen Yes Consultant /

Advisory

Board

Biotronik,

Flowonix

Medical Inc.,

Medtronic,

Nevro Corp,

and Saluda

Medical Pty.

Ltd.

$5,001-

$20,000 USD

Education /

Research

$5,001-

$20,000 USD

Company

Employee

Saluda

Medical Pty.

Ltd.


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

INS19-0181 Ganesan Baranidharan No, I do not

have any

relevant

financial

relationships


Evidence

Certification

INS19-0183 Ganesan Baranidharan Yes Education /

Research

$5,001-

$20,000 USD

Company

Employee

Nevro Corp I will support

my

presentation

and clinical

recommendati

ons with the

“best available

evidence”

from the

medical

literature.

I will refrain

from making

recommendati

ons, re:

products or

services, e.g.,

limit

presentation

to

pathophysiolo

gy, diagNosis,

and/or

research

findings


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification


have any

relevant

financial

relationships


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification


have any

relevant

financial

relationships


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

INS19-0226 Ganesan Baranidharan No I answered No to A (not applicable) Fair Balance Best Available

Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification


have any

relevant

financial

relationships


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification


have any

relevant

financial

relationships


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification


have any

relevant

financial

relationships


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification


have any

relevant

financial

relationships


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification


have any

relevant

financial

relationships


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

INS19-0369 Glenn Franken No, I do not

have any

relevant

financial

relationships


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

INS19-0394 Glenn Franken No, I do not

have any

relevant

financial

relationships


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

INS19-0272 Gavin Weekes No, I do not

have any

relevant

financial

relationships


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

INS19-0240 Gemma Alder No, I do not

have any

relevant

financial

relationships


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

INS19-0391 Gemma Alder No, I do not

have any

relevant

financial

relationships


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

INS19-0082 Clark Metzger Consultant /

Advisory

Board

$500 - $5,000

USD

Company

Employee

NeuroMicroSp

ine

No, I do not

have any

relevant

financial

relationships

I will support

my

presentation

and clinical

recommendati

ons with the

“best available

evidence”

from the

medical

literature.

I will refrain

from making

recommendati

ons, re:

products or

services, e.g.,

limit

presentation

to

pathophysiolo

gy, diagNosis,

and/or

research

findings

I will

recommend

an alternative

presenter for

this topic for

the Scientific

Program

Committee’s

consideration.

I will submit

my abstract(s)

and slides in

advance to

allow for

adequate peer

review.

I will or have

divested

myself of this

financial

relationship.


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

INS19-0085 clark metzger Education /

Research

$500 - $5,000

USD

Company

Employee

neuromicrospi

ne

No, I do not

have any

relevant

financial

relationships


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

INS19-0192 Clark Metzger Education /

Research

$500 - $5,000

USD

Company

Employee

NeuroMicroSp

ine

No, I do not

have any

relevant

financial

relationships


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

INS19-0158 Georgios Matis Yes Consultant /

Advisory

Board

$500 - $5,000

USD

Company

Employee

Boston

Scientific

I will support

my

presentation

and clinical

recommendati

ons with the

“best available

evidence”

from the

medical

literature.

Yes A new SCS

device in

Europe:

WaveWriter




Education


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

INS19-0141 Giulia Gerboni No, I do not

have any

relevant

financial

relationships

Yes The device

used is a

prototype of a

device

developed by

Syncron

Neural

Interface

TechNology




Education


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

INS19-0395 Giulia Gerboni No, I do not

have any

relevant

financial

relationships

Yes The device

used is a

prototype of a

device

developed by

Syncron

Neural

Interface

TechNology




Education


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

INS19-0210 Giuseppe Lanza Speaker

Program

$500 - $5,000

USD

No, I do not

have any

relevant

financial

relationships


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

INS19-0424 Giuseppe Lanza No, I do not

have any

relevant

financial

relationships


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

INS19-0106 gloria villalba No, I do not

have any

relevant

financial

relationships


Evidence

Scientific

Integrity

Certification

INS19-0106 gloria villalba Speaker

Program

> $20,000 USD No, I do not

have any

relevant

financial

relationships


INS19-0282 Óscar Gonçalves No, I do not

have any

relevant

financial

relationships


Integrity

Certification

INS19-0285 Óscar Gonçalves No, I do not

have any

relevant

financial

relationships


Integrity

Certification

INS19-0232 Hakan Ekmekci Education /

Research

$500 - $5,000

USD

No, I do not

have any

relevant

financial

relationships


Integrity

Certification

INS19-0045 Michael Hanes Yes Consultant /

Advisory

Board

Medtronic $5,001-

$20,000 USD

Consultant /

Advisory

Board

$5,001-

$20,000 USD

Company

Employee


my

presentation

and clinical

recommendati

ons with the

“best available

evidence”

from the

medical

literature.

I will refrain

from making

recommendati

ons, re:

products or

services, e.g.,

limit

presentation

to

pathophysiolo

gy, diagNosis,

and/or

research

findings

I will submit

my abstract(s)

and slides in

advance to

allow for

adequate peer

review.


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

INS19-0153 Michael Hanes Yes Consultant /

Advisory

Board

Medtronic $5,001-

$20,000 USD

Consultant /

Advisory

Board

$5,001-

$20,000 USD

Company

Employee


my

presentation

and clinical

recommendati

ons with the

“best available

evidence”

from the

medical

literature.

I will refrain

from making

recommendati

ons, re:

products or

services, e.g.,

limit

presentation

to

pathophysiolo

gy, diagNosis,

and/or

research

findings

I will submit

my abstract(s)

and slides in

advance to

allow for

adequate peer

review.


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

INS19-0172 Naoki Higashiyama Speaker

Program

$500 - $5,000

USD

No, I do not

have any

relevant

financial

relationships


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification

INS19-0389 Hyungmin Kim No, I do not

have any

relevant

financial

relationships


Integrity

Certification

INS19-0209 Heather Pinckard-

Dover

Education /

Research

$500 - $5,000

USD

No, I do not

have any

relevant

financial

relationships


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification


Dover

Speaker

Program

$500 - $5,000

USD

No, I do not

have any

relevant

financial

relationships


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification


Dover

No, I do not

have any

relevant

financial

relationships


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification


Dover

No, I do not

have any

relevant

financial

relationships


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certification


Dover

No, I do not

have any

relevant

financial

relationships


Evidence

Sources and

Limitations of

Data

Scientific

Integrity

Certifi

ins 2021 - abstract autho… · abstract number first name last name do you (or your spouse or...

Documents